Acorda Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Arrowhead Research USD 381.2M 542.61M 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Cipla INR 12.29B 4.8B 2025-03
Clal Biotechnology ILS -1738000 7.46M 2022-12
Compugen USD -7483000 11.98M 2024-12
CSL USD 1.98B 778M 2024-12
Cytokinetics USD -155631000 16.59M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Grifols EUR 371.86M 54.83M 2024-12
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Insmed USD -248140000 17.73M 2025-03
Ligand Pharmaceuticals USD -36216000 26.58M 2025-03
MannKind USD 22.29M 9.19M 2025-03
Merck EUR 1.01B 189M 2025-03
Moderna USD -1050000000 196M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Sanofi EUR 2.28B 1.42B 2025-03
Teva Pharmaceutical Industries USD 519M 64M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Acorda Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.